• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光滑念珠菌:特征及其耐药性综述。

Candida glabrata: a review of its features and resistance.

机构信息

IBB-Institute for Biotechnology and Bioengineering, Centre of Biological Engineering, University of Minho, 4710-057, Braga, Portugal.

出版信息

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):673-88. doi: 10.1007/s10096-013-2009-3. Epub 2013 Nov 19.

DOI:10.1007/s10096-013-2009-3
PMID:24249283
Abstract

Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous overgrowth to bloodstream infections. Once believed to be non-pathogenic, Candida glabrata was rapidly blamable for many human diseases. Year after year, these pathological circumstances are more recurrent and problematic to treat, especially when patients reveal any level of immunosuppression. These difficulties arise from the capacity of C. glabrata to form biofilms and also from its high resistance to traditional antifungal therapies. Thus, this review intends to present an excerpt of the biology, epidemiology, and pathology of C. glabrata, and detail an approach to its resistance mechanisms based on studies carried out up to the present.

摘要

假丝酵母菌属是口腔、胃肠道和阴道正常微生物群的一部分,可引起多种临床表现,从黏膜过度生长到血流感染。过去认为无致病性的光滑假丝酵母菌,近年来迅速成为许多人类疾病的罪魁祸首。年复一年,这些病理情况更频繁且更难治疗,尤其是当患者出现任何程度的免疫抑制时。这些困难源于光滑假丝酵母菌形成生物膜的能力,以及其对传统抗真菌治疗的高度耐药性。因此,本综述旨在介绍光滑假丝酵母菌的生物学、流行病学和病理学的一个摘要,并详细介绍根据目前为止的研究,对其耐药机制的研究方法。

相似文献

1
Candida glabrata: a review of its features and resistance.光滑念珠菌:特征及其耐药性综述。
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):673-88. doi: 10.1007/s10096-013-2009-3. Epub 2013 Nov 19.
2
Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.从不同身体部位分离出的念珠菌种类及其抗真菌药敏模式:白色念珠菌和光滑念珠菌生物膜的交叉分析
Med Mycol. 2017 Aug 1;55(6):624-634. doi: 10.1093/mmy/myw126.
3
A Review on Molecular Mechanisms of Antifungal Resistance in : Update and Recent Advances.抗真菌药物耐药性的分子机制综述:更新与最新进展。
Microb Drug Resist. 2021 Oct;27(10):1371-1388. doi: 10.1089/mdr.2020.0235. Epub 2021 May 5.
4
Susceptibility of clinical isolates of Candida glabrata to new triazoles.光滑念珠菌临床分离株对新型三唑类药物的敏感性
Int J Antimicrob Agents. 2003 Apr;21(4):360-1. doi: 10.1016/s0924-8579(02)00385-0.
5
Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.从医院获得性尿路感染中分离出的酵母菌:抗真菌药敏性和生物膜形成
Rev Iberoam Micol. 2014 Apr-Jun;31(2):104-8. doi: 10.1016/j.riam.2013.06.004. Epub 2013 Jun 25.
6
Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.非白色念珠菌物种的出现:流行病学、系统发育和氟康唑药敏谱。
J Mycol Med. 2018 Mar;28(1):51-58. doi: 10.1016/j.mycmed.2017.12.008. Epub 2018 Feb 1.
7
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.光滑念珠菌、近平滑念珠菌和热带念珠菌:生物学、流行病学、致病性和抗真菌耐药性。
FEMS Microbiol Rev. 2012 Mar;36(2):288-305. doi: 10.1111/j.1574-6976.2011.00278.x. Epub 2011 Jun 6.
8
The Inhibitory Effect of Human Beta-defensin-3 on Isolated from Patients with Candidiasis.人β-防御素-3 对白色念珠菌的抑制作用。
Immunol Invest. 2021 Jan;50(1):80-91. doi: 10.1080/08820139.2020.1755307. Epub 2020 Apr 22.
9
Tipping the balance both ways: drug resistance and virulence in Candida glabrata.双向权衡:光滑念珠菌的耐药性与毒力
FEMS Yeast Res. 2015 Jun;15(4):fov025. doi: 10.1093/femsyr/fov025. Epub 2015 May 15.
10
In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.在大鼠皮下模型中外体上光滑念珠菌生物膜的体内发展。
J Antimicrob Chemother. 2015 Mar;70(3):846-56. doi: 10.1093/jac/dku447. Epub 2014 Nov 17.

引用本文的文献

1
Risk of oral candidiasis: profile analysis of patients admitted to the dermatology clinic of a tertiary hospital in southeast of Brazil.口腔念珠菌病的风险:对巴西东南部一家三级医院皮肤科门诊收治患者的剖析
Rev Inst Med Trop Sao Paulo. 2025 Aug 18;67:e54. doi: 10.1590/S1678-9946202567054. eCollection 2025.
2
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in .抗真菌耐受性的诱导揭示了……中的基因和表型变化。 (注:原文不完整,“in”后面缺少具体内容)
J Fungi (Basel). 2025 Apr 4;11(4):284. doi: 10.3390/jof11040284.
3
Investigation of antifungal and antibiofilm activities of green synthesized silver nanoparticles against Candida glabrata.

本文引用的文献

1
Antifungal susceptibility and distribution of Candida spp. isolates from the University Hospital in the municipality of Dourados, State of Mato Grosso do Sul, Brazil.巴西南马托格罗索州杜拉多斯市大学医院分离的念珠菌属真菌的药敏情况和分布。
Rev Soc Bras Med Trop. 2013 May-Jun;46(3):335-9. doi: 10.1590/0037-8682-0074-2012.
2
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.棘白菌素类耐药性在光滑念珠菌中的增加:临床失败与 FKS 突变和最低抑菌浓度升高相关。
Clin Infect Dis. 2013 Jun;56(12):1724-32. doi: 10.1093/cid/cit136. Epub 2013 Mar 13.
3
绿色合成银纳米颗粒对光滑念珠菌的抗真菌和抗生物膜活性研究。
Biometals. 2025 Apr 4. doi: 10.1007/s10534-025-00680-y.
4
In Vitro Assessment of Fluconazole and Cyclosporine A Antifungal Activities: A Promising Drug Combination Against Different Species.氟康唑和环孢素A抗真菌活性的体外评估:一种针对不同物种的有前景的药物组合
J Fungi (Basel). 2025 Feb 10;11(2):133. doi: 10.3390/jof11020133.
5
meningitis in a patient with newly diagnosed acquired immunodeficiency syndrome from Sikkim, India.来自印度锡金邦的一名新诊断为获得性免疫缺陷综合征患者的脑膜炎。
Curr Med Mycol. 2024 May 7;10:e2024.345242.1542. doi: 10.22034/CMM.2024.345242.1542. eCollection 2024.
6
Evaluation of Fifteen 5,6-Dihydrotetrazolo[1,5-]quinazolines Against : Integrating In Vitro Studies, Molecular Docking, QSAR, and In Silico Toxicity Assessments.十五种5,6-二氢四唑并[1,5-]喹唑啉对……的评估:整合体外研究、分子对接、定量构效关系及计算机模拟毒性评估
J Fungi (Basel). 2024 Nov 25;10(12):816. doi: 10.3390/jof10120816.
7
Antibiofilm Activity of PDMS/TiO against through Inhibited Hydrophobic Recovery.聚二甲基硅氧烷/二氧化钛通过抑制疏水恢复对[具体对象]的抗生物膜活性 。 需注意,原文中“against”后缺少具体内容,翻译可能不太完整准确。
ACS Omega. 2024 Oct 3;9(41):42593-42601. doi: 10.1021/acsomega.4c07869. eCollection 2024 Oct 15.
8
Clinical and epidemiological aspects of yeast infections and rational use of antifungals.酵母感染的临床和流行病学方面及抗真菌药物的合理使用。
Future Microbiol. 2024;19(7):577-584. doi: 10.1080/17460913.2024.2342679. Epub 2024 Jun 17.
9
Two promising natural lipopeptides from effectively induced membrane permeabilization in .两种有前景的天然脂肽类化合物能有效诱导 中的细胞膜通透性增加。
Acta Biochim Pol. 2024 Jan 31;71:11999. doi: 10.3389/abp.2024.11999. eCollection 2024.
10
Two promising -derived antifungal lipopeptide leads AF and AF and their combined effect with fluconazole on the biofilms.两种有前景的源自[具体物质]的抗真菌脂肽先导物AF和AF及其与氟康唑对生物膜的联合作用。 (注:原文中“Two promising -derived antifungal lipopeptide leads AF and AF”表述似乎有误,推测可能是“Two promising [substance]-derived antifungal lipopeptide leads AF and BF”之类的,以上译文是基于现有内容尽量合理翻译)
Front Pharmacol. 2024 Apr 19;15:1334419. doi: 10.3389/fphar.2024.1334419. eCollection 2024.
Gain-of-function mutations in PDR1, a regulator of antifungal drug resistance in Candida glabrata, control adherence to host cells.
PDR1 中的功能获得性突变控制着光滑念珠菌对抗真菌药物耐药性的调节,控制其与宿主细胞的黏附。
Infect Immun. 2013 May;81(5):1709-20. doi: 10.1128/IAI.00074-13. Epub 2013 Mar 4.
4
Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP.通过 cDNA-AFLP 技术检测到唑类耐药性光滑念珠菌临床分离株中醛酮还原酶的过表达。
Daru. 2013 Jan 2;21(1):1. doi: 10.1186/2008-2231-21-1.
5
Gross karyotypic and phenotypic alterations among different progenies of the Candida glabrata CBS138/ATCC2001 reference strain.光滑假丝酵母 CBS138/ATCC2001 参考菌株不同后代间的总染色体组型和表型改变。
PLoS One. 2012;7(12):e52218. doi: 10.1371/journal.pone.0052218. Epub 2012 Dec 20.
6
Two unlike cousins: Candida albicans and C. glabrata infection strategies.两种不同的表亲:白念珠菌和光滑念珠菌的感染策略。
Cell Microbiol. 2013 May;15(5):701-8. doi: 10.1111/cmi.12091. Epub 2013 Jan 14.
7
STB5 is a negative regulator of azole resistance in Candida glabrata.STB5 是光滑念珠菌唑类耐药的负调控因子。
Antimicrob Agents Chemother. 2013 Feb;57(2):959-67. doi: 10.1128/AAC.01278-12. Epub 2012 Dec 10.
8
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.念珠菌属菌种:当前流行病学、致病性、生物膜形成、天然抗真菌产品和新的治疗选择。
J Med Microbiol. 2013 Jan;62(Pt 1):10-24. doi: 10.1099/jmm.0.045054-0. Epub 2012 Nov 22.
9
Functional genomic analysis of Candida glabrata-macrophage interaction: role of chromatin remodeling in virulence.光滑念珠菌与巨噬细胞相互作用的功能基因组分析:染色质重塑在毒力中的作用。
PLoS Pathog. 2012;8(8):e1002863. doi: 10.1371/journal.ppat.1002863. Epub 2012 Aug 16.
10
A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance.念珠菌生物膜诱导的细胞外基质葡聚糖传递途径:与耐药性相关。
PLoS Pathog. 2012;8(8):e1002848. doi: 10.1371/journal.ppat.1002848. Epub 2012 Aug 2.